Trial intelligence / Profile preview

Impact of Venarus on MCP-1 in Varicose Veins

NCT04933591Phase 4Completed

Sponsor
Pirogov Russian National Research Medical University
Start
Sep 2020
Primary completion
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of micronized purified flavonoid fraction in Varicose Veins, sponsored by Pirogov Russian National Research Medical University. Started Sep 2020; status: completed.

02

Drugs

micronized purified flavonoid fraction
03

Conditions

Varicose Veins

Beyond the preview

Go deeper on NCT04933591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04933591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call